CRIS Current Research Information System

Cavo, M., Sonneveld, P., Moreau, P., Blade, J., Goldschmidt, H., San Miguel, J.F., et al. (2012). Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies.

Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies

CAVO, MICHELE;Marzocchi, G;TERRAGNA, CAROLINA
2012
2012
Blood
749
749
Cavo, M., Sonneveld, P., Moreau, P., Blade, J., Goldschmidt, H., San Miguel, J.F., et al. (2012). Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies.
Cavo, M; Sonneveld, P; Moreau, P; Blade, J; Goldschmidt, H; San Miguel, JF; Attal, M; Avet-Loiseau, H; Blau, WI; Facon, T; Gutierrez, N; Harousseau, J...espandi
4.02 Riassunto (Abstract)
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/396505
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 4
social impact